Nutra Pharma Announces Fourth Quarter Sales for Its Over-the-Counter (OTC) Pain Reliever, Cobroxin
Nutra Pharma Has Announced That Its Over-the-Counter (OTC) Pain Reliever, Cobroxin, Has Generated Sales Totaling $583,955 for the Fourth Quarter Ending December 31, 2009
PLANTATION, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that sales of its recently launched over-the-counter pain reliever, Cobroxin, totaled $583,955 for the fourth quarter ending December 31, 2009.
“We were extremely pleased ...
[ more ]
